SCHEMBL28009488

SCHEMBL28009488

CN1C=CC=NC1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6906143 0.72
SCHEMBL12570744 0.72
SCHEMBL28550006 0.70
SCHEMBL4650148 0.70
SCHEMBL22308091 0.70
SCHEMBL24667243 0.70
SCHEMBL27777052 0.70
SCHEMBL27724806 0.70
SCHEMBL28254431 0.70
SCHEMBL28176916 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103987698-B 2-phenylaminopyrimidine derivatives as kinase LRRK2 modulators for the treatment of Parkinson's disease HOFFMAN-LA ROCHE LTD. (CH) 2016-04-20 CN disclosed
CN-102548981-B N1-acyl-5-fluoropyrimidinone derivatives DOW AGROSCIENCES LLC 2015-05-13 CN disclosed
CN-103313978-B Pyrazole aminopyrimidine derivatives as LRRK2 modulators HOFFMANN LA ROCHE 2015-04-15 CN disclosed